Felix Biotechnology
ClosedWe’re creating programmable therapies
San Francisco, United States · Founded 2019 · $150K raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2019
- Website
- felixbt.com
- Total Funding
- $150K
- Last Round
- $150K GrantMar 2020
- Rounds
- 1
About
We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
Summary
Felix Biotechnology is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $150K in total across 1 round, most recently a $150K Grant round in Mar 2020. Investors include Small Business Innovation Research and Cystic Fibrosis Foundation.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2020
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...